Novocure has several additional ongoing or completed clinical trials exploring the use of Tumor Treating Fields therapy in the treatment of glioblastoma, non-small cell lung cancer and pancreatic ...

Pancreatic cancer is a highly lethal malignancy, with PDAC accounting for ~92% of all cases. A researcher poring over test results, illustrating the breakthrough potential of biotechnology.

US-based PanTher Therapeutics has initiated a trial of its chemotherapy-eluting patch, which it hopes will make cancer therapy more tolerable. The Phase Ib study (NCT06673017) is investigating PTM-101 ...

Detailed price information for Mustang Bio Inc (MBIO-Q) from The Globe and Mail including charting and trades.

Non-Small Cell Lung Cancer Market grows as immunotherapy approvals by Merck & Bristol-Myers reshape global treatment pathways. Anurag Tiwari Orion Market Research Pvt Ltd +91 91798 28694 email us here ...

PRISM-1, the ongoing registrational, Phase 3 study evaluating quemliclustat plus chemotherapy as a first-line treatment for metastatic pancreatic cancer, is expected to be fully enrolled by the ...

Lupus can be debilitating and sometimes deadly for the 3 million people who have it. A treatment called CAR T appears to stop it in its tracks.

Fraction, PDF, Vitamin C, Anticancer, Pancreatic Cancer, Cervical Cancer, Small-Cell Lung Cancer Share and Cite: Konno, S. , Penunuri, A. , Wong, J. , Fullerton, S. and Choudhury, M. (2025) Anticancer ...